Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 740

1.

Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment.

Bagnasco D, Heffler E, Testino E, Passalacqua G, Canonica GW.

Expert Opin Drug Metab Toxicol. 2019 Jan 11. doi: 10.1080/17425255.2019.1568409. [Epub ahead of print]

PMID:
30632416
2.

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life.

Lombardi C, Bagnasco D, Caruso C, D'Amato M, Menzella F, Milanese M, Senna G, Canonica GW, Passalacqua G.

Pulm Pharmacol Ther. 2018 Dec 28. pii: S1094-5539(18)30277-3. doi: 10.1016/j.pupt.2018.12.003. [Epub ahead of print]

PMID:
30597278
3.

Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria.

Folci M, Heffler E, Canonica GW, Furlan R, Brunetta E.

J Immunol Res. 2018 Nov 21;2018:5615109. doi: 10.1155/2018/5615109. eCollection 2018. Review.

4.

ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy".

Bosnic-Anticevich S, Costa E, Menditto E, Lourenço O, Novellino E, Bialek S, Briedis V, Buonaiuto R, Chrystyn H, Cvetkovski B, Capua SD, Kritikos V, Mair A, Orlando V, Paulino E, Salimäki J, Söderlund R, Tan R, Williams DM, Wroczynski P, Agache I, Ansotegui IJ, Anto JM, Bedbrook A, Bachert C, Bewick M, Bindslev-Jensen C, Brozek J, Canonica GW, Cardona V, Carr W, Casale T, Chavannes NH, Correia de Sousa J, Cruz AA, Czarlewski W, De Carlo G, Demoly P, Devillier P, Dykewicz MS, Gaga M, El-Gamal Y, Fonseca J, Fokkens WJ, Guzmán MA, Haahtela T, Hellings PW, Illario M, Ivancevich JC, Just J, Kaidashev I, Khaitov M, Khaltaev N, Keil T, Klimek L, Kowalski ML, Kuna P, Kvedariene V, Larenas-Linnemann D, Laune D, Le LTT, Carlsen KCL, Mahboub B, Maier D, Malva J, Manning P, Morais-Almeida M, Mösges R, Mullol J, Münter L, Murray R, Naclerio R, Namazova-Baranova L, Nekam K, Nyembue TD, Okubo K, O'Hehir RE, Ohta K, Okamoto Y, Onorato GL, Palkonen S, Panzner P, Papadopoulos NG, Park HS, Pawankar R, Pfaar O, Phillips J, Plavec D, Popov TA, Potter P, Prokopakis EP, Roller-Wirnsberger RE, Rottem M, Ryan D, Samolinski B, Sanchez-Borges M, Schunemann HJ, Sheikh A, Sisul JC, Somekh D, Stellato C, To T, Todo-Bom A, Tomazic PV, Toppila-Salmi S, Valero A, Valiulis A, Valovirta E, Ventura MT, Wagenmann M, Wallace D, Waserman S, Wickman M, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zidarn M, Zuberbier T, Bousquet J.

Allergy. 2018 Dec 18. doi: 10.1111/all.13701. [Epub ahead of print]

PMID:
30565275
5.

The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials.

Bagnasco D, Milanese M, Rolla G, Lombardi C, Bucca C, Heffler E, Canonica GW, Passalacqua G.

World Allergy Organ J. 2018 Dec 6;11(1):34. doi: 10.1186/s40413-018-0210-7. eCollection 2018.

6.

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma.

Bagnasco D, Caminati M, Ferrando M, Aloè T, Testino E, Canonica GW, Passalacqua G.

Biomed Res Int. 2018 Nov 5;2018:5698212. doi: 10.1155/2018/5698212. eCollection 2018. Review.

7.

Adherence to treatment in allergic respiratory diseases.

Baiardini I, Novakova S, Mihaicuta S, Oguzulgen IK, Canonica GW.

Expert Rev Respir Med. 2018 Dec 5:1-10. doi: 10.1080/17476348.2019.1554438. [Epub ahead of print]

PMID:
30518277
8.

The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.

Djukanovic R, Adcock IM, Anderson G, Bel EH, Canonica GW, Cao H, Chung KF, Davies DE, Genton C, Gibson-Latimer T, Hamerlijnck D, Heuvelin E, Louis R, Korn S, Kots M, Kwon N, Naddaf R, Wagers SS; SHARP Clinical Research Collaboration; Members of the CRC-SHARP.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801671. doi: 10.1183/13993003.01671-2018. Print 2018 Nov. No abstract available.

PMID:
30498052
9.

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.

Marzano AV, Genovese G, Casazza G, Fierro MT, Dapavo P, Crimi N, Ferrucci S, Pepe P, Liberati S, Pigatto PD, Offidani A, Martina E, Girolomoni G, Rovaris M, Foti C, Stingeni L, Cristaudo A, Canonica GW, Nettis E, Asero R.

J Eur Acad Dermatol Venereol. 2018 Nov 19. doi: 10.1111/jdv.15350. [Epub ahead of print]

PMID:
30451325
10.

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study.

Canonica GW, Rottoli P, Bucca C, Zappa MC, Michetti G, Macciocchi B, Caruso C, Santus P, Bartezaghi M, Rigoni L; PROXIMA study centers.

World Allergy Organ J. 2018 Nov 1;11(1):33. doi: 10.1186/s40413-018-0214-3. eCollection 2018.

11.

Strategies to reduce corticosteroid-related adverse events in asthma.

Heffler E, Bagnasco D, Canonica GW.

Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):61-67. doi: 10.1097/ACI.0000000000000493.

PMID:
30407207
12.

Will precision medicine be available for all patients in the near future?

Gómez RM, Ansotegui I, Canonica GW.

Curr Opin Allergy Clin Immunol. 2019 Feb;19(1):75-80. doi: 10.1097/ACI.0000000000000491.

PMID:
30394897
13.

The Severe Asthma Network in Italy: Findings and Perspectives.

Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, Senna G, Canonica GW; SANI Network.

J Allergy Clin Immunol Pract. 2018 Oct 25. pii: S2213-2198(18)30673-1. doi: 10.1016/j.jaip.2018.10.016. [Epub ahead of print]

PMID:
30368004
14.

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

Bousquet J, Hellings PW, Agache I, Amat F, Annesi-Maesano I, Ansotegui IJ, Anto JM, Bachert C, Bateman ED, Bedbrook A, Bennoor K, Bewick M, Bindslev-Jensen C, Bosnic-Anticevich S, Bosse I, Brozek J, Brussino L, Canonica GW, Cardona V, Casale T, Cepeda Sarabia AM, Chavannes NH, Cecchi L, Correia de Sousa J, Costa E, Cruz AA, Czarlewski W, De Carlo G, De Feo G, Demoly P, Devillier P, Dykewicz MS, El-Gamal Y, Eller EE, Fonseca JA, Fontaine JF, Fokkens WJ, Guzmán MA, Haahtela T, Illario M, Ivancevich JC, Just J, Kaidashev I, Khaitov M, Kalayci O, Keil T, Klimek L, Kowalski ML, Kuna P, Kvedariene V, Larenas-Linnemann D, Laune D, Le LTT, Carlsen KL, Lourenço O, Mahboub B, Mair A, Menditto E, Milenkovic B, Morais-Almeida M, Mösges R, Mullol J, Murray R, Naclerio R, Namazova-Baranova L, Novellino E, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Onorato GL, Palkonen S, Panzner P, Papadopoulos NG, Park HS, Paulino E, Pawankar R, Pfaar O, Plavec D, Popov TA, Potter P, Prokopakis EP, Rottem M, Ryan D, Salimäki J, Samolinski B, Sanchez-Borges M, Schunemann HJ, Sheikh A, Sisul JC, Rajabian-Söderlund R, Sooronbaev T, Stellato C, To T, Todo-Bom AM, Tomazic PV, Toppila-Salmi S, Valero A, Valiulis A, Valovirta E, Ventura MT, Wagenmann M, Wang Y, Wallace D, Waserman S, Wickman M, Yorgancioglu A, Zhang L, Zhong N, Zidarn M, Zuberbier T; Mobile Airways Sentinel Network (MASK) Study Group.

J Allergy Clin Immunol. 2018 Sep 29. pii: S0091-6749(18)31359-9. doi: 10.1016/j.jaci.2018.08.049. [Epub ahead of print]

PMID:
30273709
15.

A Charter to Improve Patient Care in Severe Asthma.

Menzies-Gow A, Canonica GW, Winders TA, Correia de Sousa J, Upham JW, Fink-Wagner AH.

Adv Ther. 2018 Oct;35(10):1485-1496. doi: 10.1007/s12325-018-0777-y. Epub 2018 Sep 4.

16.

Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.

Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimäki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d'Alcontres M, Gopalan G, Tran TN, Price D.

J Allergy Clin Immunol Pract. 2018 Sep 1. pii: S2213-2198(18)30552-X. doi: 10.1016/j.jaip.2018.08.016. [Epub ahead of print]

PMID:
30179741
17.

Allergen immunotherapy as add-on to biologic agents.

Lombardi C, Canonica GW, Passalacqua G.

Curr Opin Allergy Clin Immunol. 2018 Dec;18(6):502-508. doi: 10.1097/ACI.0000000000000479.

PMID:
30148718
18.

Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.

Brunetta E, Shiffer D, Folci M, Achenza MIS, Puggioni F, Heffler E, Furlan R, Canonica GW.

Case Reports Immunol. 2018 Jul 22;2018:8067610. doi: 10.1155/2018/8067610. eCollection 2018.

19.

Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps.

Heffler E, Malvezzi L, Boita M, Brussino L, De Virgilio A, Ferrando M, Puggioni F, Racca F, Stomeo N, Spriano G, Canonica GW.

Expert Rev Clin Immunol. 2018 Sep;14(9):731-737. doi: 10.1080/1744666X.2018.1512407. Epub 2018 Aug 22.

PMID:
30107759
20.

Latex Allergy and Occupational Exposure: The Patient's Perspective.

Baiardini I, Di Leo E, Molinengo G, Braido F, Canonica GW, Nettis E.

J Investig Allergol Clin Immunol. 2018 Aug;28(4):269-271. doi: 10.18176/jiaci.0257. No abstract available.

Supplemental Content

Loading ...
Support Center